Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: BCMA, CAR-T, CD19 Sep 01 | 2020Thoughts on Allogene’s AlloCAR Program; Q2 2020 Earnings Call SummaryPurchase Blast
$599
Posted in: BCMA, CAR-T, CD19 Sep 01 | 2020BMS Highlights Ide-cel FDA Re-submission; Q2 2020 Earnings CallPurchase Blast
$599
Posted in: Insulin Delivery Aug 31 | 2020Medtronic's 770G Pump Approved in Peds Down to 2 Years of AgePurchase Blast
$599
Posted in: GLP-1RA Aug 31 | 2020New Oral Sema High-Dose and Flexible Administration Ph1 Trials from NovoPurchase Blast
$599
Posted in: Basal Insulin Aug 31 | 2020Biocon/Mylan Launch Semglee in US at 65% WAC Discount to LantusPurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 Aug 31 | 2020Thoughts on Gilead's Recent FDA Approval for Tecartus (KTE-X19) in R/R Mantle Cell LymphomaPurchase Blast
$599
Posted in: SGLT2i Aug 30 | 2020DAPA-CKD Results Highly Positive; AZ Winning in SGLT2i LCMPurchase Blast
$599
Posted in: Basal Insulin Aug 27 | 2020Lannett To Forego Bs-Glargine U100 Interchangeability; Lannett Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Aug 25 | 2020Medtronic CY Q2 ’20 (FY Q1 ’21) Earnings UpdatePurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 Aug 25 | 2020Kymriah Sales Unaffected By COVID-19, but Ph3 Adult ALL Trial Withdrawn; Novartis Q2 2020 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 24 | 2020Bayer Commits ~$100M in One Drop Series CPurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 21 | 2020One Drop Launches New Membership Program; AZ Partners with RenalytixAI for Chronic Disease Precision MedicinePurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 20 | 2020Sensyne to Launch New Diabetes Remote Monitoring SoftwarePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Glucagon Aug 18 | 2020AZ to Withdraw Qtrilmet Marketing Authorization; CHMP Agenda August 17-20Purchase Blast
$599
Posted in: Dual/triple agonist Aug 18 | 2020Lilly's Next-gen Tirzepatide for Oral Delivery? New Lilly GIP/GLP Dual Agonist Ph1 StudiesPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Other Aug 14 | 2020Novo Invests in Upgrading Kalundborg Manufacturing FacilityPurchase Blast